ONLINE DATABASE SEARCH - HIV-LS-315-MEMO
1. 44792 HIV-LS-315; SCIFINDER-HIV-2/1/2005
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, Edmund NC, Holmes, Rebecca K, Craig, Heather M, Klein, Kevin C, Lingappa, Jaisri R, Malim, Michael H, and Sheehy, Ann M
Current Biology 2005. 15(2): 166-170
2. 44793 HIV-LS-315; PUBMED-HIV-2/9/2005
Dissecting the Effects of DNA Polymerase and Ribonuclease H Inhibitor Combinations on HIV-1 Reverse-Transcriptase Activities
Shaw-Reid, CA, Feuston, B, Munshi, V, Getty, K, Krueger, J, Hazuda, DJ, Parniak, MA, Miller, MD, and Lewis, D
Biochemistry 2005. 44(5): 1595-1606
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15683243&dopt=abstract
3. 44794 HIV-LS-315; SCIFINDER-HIV-2/1/2005
Synthesis and antiviral activity of novel acyclic nucleosides in the 5-alkynyl- and 6-alkylfuro[2,3-d]pyrimidine series
Amblard, Franck, Aucagne, Vincent, Guenot, Pierre, Schinazi, Raymond F, and Agrofoglio, Luigi A
Bioorganic & Medicinal Chemistry 2005. 13(4): 1239-1248
4. 44795 HIV-LS-315; PUBMED-HIV-2/9/2005
Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells
Daniel, R, Marusich, E, Argyris, E, Zhao, RY, Skalka, AM, and Pomerantz, RJ
J Virol 2005. 79(4): 2058-65
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15681408&dopt=abstract
5. 44796 HIV-LS-315; SCIFINDER-HIV-2/1/2005
VCAM-1 Expression on CD8+ Cells Correlates with Enhanced Anti-HIV Suppressing Activity
Diaz, Leyla S, Foster, Hillary, Stone, Mars R, Fujimura, Sue, Relman, David A, and Levy, Jay A
Journal of Immunology 2005. 174(3): 1574-1579
6. 44797 HIV-LS-315; PUBMED-HIV-2/9/2005
Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives
Huang, L, Yuan, X, Yu, D, Lee, KH, and Ho, Chen C
Virology 2005. 332(2): 623-8
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15680427&dopt=abstract
7. 44798 HIV-LS-315; SCIFINDER-HIV-2/1/2005
Indole, azaindole and related heterocyclic n-substituted piperazine derivatives
Yeung, Kap-Sun, Farkas, Michelle, Kadow, John F, Meanwell, Nicholas A, Taylor, Malcolm, Johnston, David, Coulter, Thomas Stephen, and Wright, JJKim
PATENT: WO 2005004801 ISSUE DATE: 20050120
APPLICATION: 2004 PP: 226 pp.
ASSIGNEE: (Bristol-Myers Squibb Company, USA
8. 44799 HIV-LS-315; SCIFINDER-HIV-2/1/2005
Human Immunodeficiency Virus Protease Inhibitors Accumulate into Cultured Human Adipocytes and Alter Expression of Adipocytokines
Vernochet, Cecile, Azoulay, Stephane, Duval, Daniele, Guedj, Roger, Cottrez, Francoise, Vidal, Hubert, Ailhaud, Gerard, and Dani, Christian
Journal of Biological Chemistry 2005. 280(3): 2238-2243
9. 44800 HIV-LS-315; SCIFINDER-HIV-2/1/2005
Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors
Savarino, Andrea
PATENT: US 20050009810 ISSUE DATE: 20050113
APPLICATION: 2004-62372 PP: 20 pp.
ASSIGNEE: (Italy)
10. 44801 HIV-LS-315; SCIFINDER-HIV-2/1/2005
Antiviral compounds derived from naturally occurring proteins
Pellegrini, Antonio and Engels, Monika
Current Medicinal Chemistry: Anti-Infective Agents 2005. 4(1): 55-66
11. 44802 HIV-LS-315; PUBMED-HIV-2/9/2005
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide
Patel, IH, Zhang, X, Nieforth, K, Salgo, M, and Buss, N
Clin Pharmacokinet 2005. 44(2): 175-86
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15656696&dopt=abstract
12. 44803 HIV-LS-315; PUBMED-HIV-2/9/2005
Resistance to dual nucleoside reverse-transcriptase inhibitors in children infected with HIV clade A/E
Lolekha, R, Sirivichayakul, S, Siangphoe, U, Pancharoen, C, Kaewchana, S, Apateerapong, W, Mahanontharit, A, Chotpitayasunondh, T, Ruxrungtham, K, Phanuphak, P, and Ananworanich, J
Clin Infect Dis 2005. 40(2): 309-12
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15655753&dopt=abstract
13. 44804 HIV-LS-315; SCIFINDER-HIV-2/1/2005
PEM-3-like proteins and encoding nucleic acids and their use in antiviral therapy and drug screening
Greener, Tsvika and Ben-Avraham, Danny
PATENT: WO 2005001485 ISSUE DATE: 20050106
APPLICATION: 2004 PP: 175 pp.
ASSIGNEE: (Proteologics, Inc. USA
14. 44805 HIV-LS-315; SCIFINDER-HIV-2/1/2005
Compositions for down-regulation of CCR5 expression and reducing HIV entry into T-cells
Redfield, Robert R, Amoroso, Anthony, Davis, Charles E, and Heredia, Alonsa
PATENT: WO 2005001027 ISSUE DATE: 20050106
APPLICATION: 2004 PP: 58 pp.
ASSIGNEE: (University of Maryland Biotechnology Institute, USA
15. 44806 HIV-LS-315; PUBMED-HIV-2/9/2005
Rationale for maintenance of the M184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients
Turner, D, Brenner, BG, Routy, JP, Petrella, M, and Wainberg, MA
New Microbiol 2004. 27(2 Suppl 1): 31-9
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15646062&dopt=abstract
16. 44807 HIV-LS-315; WOS-HIV-1/30/2005
Inhibition of HIV-1 infection by monoclonal antibodies to carbohydrates of Schistosoma mansoni
Antonio, M, Mello, G, Mascarenhas, RE, Ferraro, GA, Harn, D, Galvao-Castro, B, and Bou-Habib, DC
MEDICAL MICROBIOLOGY AND IMMUNOLOGY 2005. 194(1-2): 61-65, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226096200009
17. 44808 HIV-LS-315; WOS-HIV-1/30/2005
Enfuvirtide, first fusion inhibitor in the treatment of human immunodeficiency virus infection - Action mechanism and pharmacokinetics
Raffi, F
MEDECINE ET MALADIES INFECTIEUSES 2004. 34: 3-7, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225859300002
18. 44809 HIV-LS-315; WOS-HIV-1/30/2005
Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade A and clade B V3 domains are common in patient sera from cameroon, but their neutralization activity is usually restricted by epitope masking
Krachmarov, C, Pinter, A, Honnen, WJ, Gorny, MK, Nyambi, PN, Zolla-Pazner, S, and Kayman, SC
JOURNAL OF VIROLOGY 2005. 79(2): 780-790, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226149700013
19. 44810 HIV-LS-315; WOS-HIV-1/30/2005
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1
Zwick, MB, Jensen, R, Church, S, Wang, M, Stiegler, G, Kunert, R, Katinger, H, and Burton, DR
JOURNAL OF VIROLOGY 2005. 79(2): 1252-1261, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226149700059
20. 44811 HIV-LS-315; WOS-HIV-1/30/2005
Changes in the vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease
Adekale, MA, Cane, PA, and McCrae, MA
JOURNAL OF MEDICAL VIROLOGY 2005. 75(2): 195-201, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226009400003
21. 44812 HIV-LS-315; WOS-HIV-1/30/2005
Advances in the diagnosis and treatment of acute human immunodeficiency virus type 1 (HIV-1) infection
Miro, JM, Sued, O, Plana, M, Pumarola, T, and Gallart, T
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2004. 22(10): 643-659, 17
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226008500003
22. 44813 HIV-LS-315; WOS-HIV-1/30/2005
Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases
Sarafianos, SG, Das, K, Hughes, SH, and Arnold, E
CURRENT OPINION IN STRUCTURAL BIOLOGY 2004. 14(6): 716-730, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226045600012
23. 44814 HIV-LS-315; WOS-HIV-1/30/2005
Cyclo-oxygenase type 2-dependent prostaglandin E-2 secretion is involved in retrovirus-induced T-cell dysfunction in mice
Rahmouni, S, Aandahl, EM, Nayjib, B, Zeddou, M, Giannini, S, Verlaet, M, Greimers, R, Boniver, J, Tasken, K, and Moutschen, M
BIOCHEMICAL JOURNAL 2004. 384: 469-476, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226084000003
24. 44815 HIV-LS-315; WOS-HIV-1/30/2005
Inhibition of HIV type 1 replication using lentiviral-mediated delivery of mutant tRNA(Lys3) A58U
Renda, MJ, Bradel-Tretheway, B, Planelles, V, Bambara, RA, and Dewhurst, S
AIDS RESEARCH AND HUMAN RETROVIRUSES 2004. 20(12): 1324-1334, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226049200007
25. 44816 HIV-LS-315; WOS-HIV-2/6/2005
HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases
Devroe, E, Silver, PA, and Engelman, A
VIROLOGY 2005. 331(1): 181-189, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226210500017
26. 44817 HIV-LS-315; WOS-HIV-2/6/2005
New analogues of the antitumor alkaloid girolline: The 4-deazathiogirolline series
Nay, B, Schiavi, B, Ahond, A, Poupat, C, and Potier, P
SYNTHESIS-STUTTGART 2005.(1): 97-101, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226258700016
27. 44818 HIV-LS-315; WOS-HIV-2/6/2005
Human immunodeficiency virus - one of nature's greatest evolutionary machines
Martin, D and Williamson, C
SOUTH AFRICAN JOURNAL OF SCIENCE 2004. 100(9-10): 479-482, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226240500020
28. 44819 HIV-LS-315; WOS-HIV-2/6/2005
Pharmacokinetic and metabolic studies of retrojusticidin B, a potential anti-viral lignan, in rats
Wang, CY, Sun, SW, and Lee, SS
PLANTA MEDICA 2004. 70(12): 1161-1165, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226292900011
29. 44820 HIV-LS-315; WOS-HIV-2/6/2005
Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors
Giannecchini, S, Pistello, M, Del, Santo B, Rovero, P, Sichi, O, and Bendinelli, M
MICROBIOLOGICA 2004. 27(2): 77-84, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226119200011
30. 44821 HIV-LS-315; WOS-HIV-2/6/2005
A new prospective against HIV infection: Induction of murin CCR5-downregulating antibodies
Barassi, C, Marenzi, C, Pastori, C, Longhi, R, Lazzarin, A, and Lopalco, L
MICROBIOLOGICA 2004. 27(2): 85-94, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226119200012
31. 44822 HIV-LS-315; WOS-HIV-2/6/2005
Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy
Fridkin, M, Tsubery, H, Tzehoval, E, Vonsover, A, Biondi, L, Filira, F, and Rocchi, R
JOURNAL OF PEPTIDE SCIENCE 2005. 11(1): 37-44, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226391100005
32. 44823 HIV-LS-315; WOS-HIV-2/6/2005
Study on the interactions between anti-HIV-1 active compounds with trans-activation response RNA by affinity capillary electrophoresis
Li, D, Zhang, XX, Chang, WB, Wei, L, and Yang, M
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 2005. 814(1): 99-104, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226272100013
33. 44824 HIV-LS-315; WOS-HIV-2/6/2005
Constituents from the stems of Hibiscus taiwanensis
Wu, PL, Wu, TS, He, CX, Su, CH, and Lee, KH
CHEMICAL & PHARMACEUTICAL BULLETIN 2005. 53(1): 56-59, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226329000012
34. 44825 HIV-LS-315; WOS-HIV-2/6/2005
Topochemical model for prediction of anti-HIV activity of HEPT analogs
Bajaj, S, Sambi, SS, and Madan, AK
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2005. 15(2): 467-469, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226344800042
35. 44826 HIV-LS-315; WOS-HIV-2/6/2005
Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure-activity correlations with related alkaloids
Kashiwada, Y, Aoshima, A, Ikeshiro, Y, Chen, YP, Furukawa, H, Itoigawa, M, Fujioka, T, Mihashi, K, Cosentino, LM, Morris-Natschke, SL, and Lee, KH
BIOORGANIC & MEDICINAL CHEMISTRY 2005. 13(2): 443-448, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226343800014